Clinical Trials on Attenuation of Bright Light in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Custom Pharmaceuticals Limited
- Nestlé Health Science Belgium
- Pedro Gamito
- Advanced Life Solutions
- JMI Laboratories
- Dr. Praveen B.H
- Fogarty International Center of the National Institute of Health
- Stannah Stairlifts
- Hospital Samaritano Paulista
- The Fred Hollows Foundation, Australia
- Physip S.A
- Janssen (China) Research & Development Center
- UZ Leuven, campus Pellenberg (Belgium)
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- Familien Hede Nielsens Fond
- IN-JET APS
- Markham Stouffville Hospital
- Prof. Jacques SCHRENZEL
- Hazelden Betty Ford Foundation
- View Full List
Medical Conditions
- Endocarditis Infective
- Predictors of Atrial Fibrillation Recurrences
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Skull Base Neoplasms
- Epidemic Hemorrhagic Fever
- Pulmonary Adenocarcinoma
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Multisystem Proteinopathy
- Painless Hysteroscopy
- Ewing's Family Tumors
- Gullian Barre Syndrome
- Closure; Foramen Ovale
- Chlamydophila Infections
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Spine Surgeries
- Psoriasis, Arthritic
- Fetus or Neonate Affected by External Version Before Labor
- Childhood Langerhans Cell Histiocytosis
- Fracture Dislocation of Cervical Spine
- Tay-Sachs Disease Ganglioside
- View Full List
Drug Interventions
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Qingkailing injection 40 ml
- Adapalene Gel 0.3%
- Glimepiride
- Neihulizumab
- Esomeprazole 40mg before
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Estradiol+Drospirenone
- EFV +TVA
- Redifferentiation with retinoid acid
- Azelastine hydrochloride (BAYR9258)
- Semapimod
- Vehicle
- High dose pantoprazole infusion
- Palliative care group first-line scheme
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Adriamycin
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Cereport
- Chemotherapeutic Agent
- View Full List
CROs by country
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Congo
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Guinea
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Netherlands
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Norway
- Contract Research Organizations in Oman
- Contract Research Organizations in Panama
- Contract Research Organizations in Suriname
- CRO list by country